Cronos Group Inc. (NASDAQ:CRON - Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 3,570,000 shares, a drop of 14.4% from the April 30th total of 4,170,000 shares. Based on an average trading volume of 1,760,000 shares, the short-interest ratio is currently 2.0 days. Currently, 1.8% of the shares of the company are short sold.
Institutional Investors Weigh In On Cronos Group
A number of large investors have recently bought and sold shares of CRON. Tower Research Capital LLC TRC raised its position in Cronos Group by 140.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock valued at $28,000 after purchasing an additional 8,019 shares in the last quarter. Thompson Davis & CO. Inc. bought a new position in Cronos Group in the fourth quarter valued at about $29,000. SBI Securities Co. Ltd. acquired a new position in Cronos Group during the fourth quarter worth about $30,000. Jones Financial Companies Lllp lifted its holdings in shares of Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after acquiring an additional 6,520 shares during the last quarter. Finally, Aigen Investment Management LP acquired a new stake in shares of Cronos Group in the 1st quarter valued at approximately $35,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.
Cronos Group Trading Up 0.3%
Shares of NASDAQ:CRON traded up $0.01 during trading on Thursday, reaching $1.94. 1,074,405 shares of the stock were exchanged, compared to its average volume of 1,311,752. Cronos Group has a 12 month low of $1.60 and a 12 month high of $2.58. The stock has a 50-day moving average price of $1.88 and a 200-day moving average price of $1.93. The firm has a market cap of $745.79 million, a PE ratio of -14.88, a PEG ratio of 1.74 and a beta of 1.06.
Cronos Group (NASDAQ:CRON - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.01. Cronos Group had a negative return on equity of 2.56% and a negative net margin of 42.65%. The firm had revenue of $33.62 million for the quarter, compared to analyst estimates of $45.44 million. On average, sell-side analysts expect that Cronos Group will post -0.03 earnings per share for the current fiscal year.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
